Jay A. Cherner

1.2k total citations
17 papers, 985 citations indexed

About

Jay A. Cherner is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Jay A. Cherner has authored 17 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Jay A. Cherner's work include Helicobacter pylori-related gastroenterology studies (7 papers), Neuroendocrine Tumor Research Advances (5 papers) and Polyamine Metabolism and Applications (4 papers). Jay A. Cherner is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (7 papers), Neuroendocrine Tumor Research Advances (5 papers) and Polyamine Metabolism and Applications (4 papers). Jay A. Cherner collaborates with scholars based in United States. Jay A. Cherner's co-authors include Jerry D. Gardner, Robert T. Jensen, K.E. McArthur, Martin J. Collen, John M. Howard, J. A. Barnard, Carol M. McCutchen, Robert J. Coffey, R. Daniel Beauchamp and Paul N. Maton and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Annals of Internal Medicine.

In The Last Decade

Jay A. Cherner

17 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay A. Cherner United States 11 420 332 330 208 146 17 985
J Dämmrich Germany 16 177 0.4× 448 1.3× 160 0.5× 178 0.9× 32 0.2× 52 1.0k
Hideo Ohtsuka Japan 20 178 0.4× 309 0.9× 360 1.1× 562 2.7× 82 0.6× 105 1.4k
Y Yamamura Japan 18 56 0.1× 441 1.3× 257 0.8× 178 0.9× 27 0.2× 31 1.1k
Kazunori Shibao Japan 17 138 0.3× 596 1.8× 423 1.3× 456 2.2× 17 0.1× 81 1.3k
Thomas Pusl Germany 16 238 0.6× 248 0.7× 300 0.9× 275 1.3× 10 0.1× 32 869
Nobuyuki Nishizawa Japan 20 76 0.2× 437 1.3× 189 0.6× 233 1.1× 26 0.2× 50 853
P. M. van Koetsveld Netherlands 22 518 1.2× 240 0.7× 277 0.8× 276 1.3× 234 1.6× 41 1.2k
Seiki Matsuno Japan 13 78 0.2× 157 0.5× 265 0.8× 365 1.8× 16 0.1× 20 688
Christine Joseph United States 15 172 0.4× 320 1.0× 82 0.2× 190 0.9× 20 0.1× 25 966
Takashi Tasaki Japan 15 114 0.3× 237 0.7× 179 0.5× 137 0.7× 31 0.2× 53 678

Countries citing papers authored by Jay A. Cherner

Since Specialization
Citations

This map shows the geographic impact of Jay A. Cherner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay A. Cherner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay A. Cherner more than expected).

Fields of papers citing papers by Jay A. Cherner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay A. Cherner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay A. Cherner. The network helps show where Jay A. Cherner may publish in the future.

Co-authorship network of co-authors of Jay A. Cherner

This figure shows the co-authorship network connecting the top 25 collaborators of Jay A. Cherner. A scholar is included among the top collaborators of Jay A. Cherner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay A. Cherner. Jay A. Cherner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Cherner, Jay A. & John L. Sawyers. (1992). Benefit of resection of metastatic gastrinoma in multiple endocrine neoplasia type I. Gastroenterology. 102(3). 1049–1053. 21 indexed citations
2.
Cherner, Jay A., et al.. (1990). Atrial natriuretic factor activates membrane-bound guanylate cyclase of chief cells. Life Sciences. 47(7). 669–677. 8 indexed citations
3.
Cherner, Jay A., et al.. (1990). Cholinergic desensitization of pepsinogen secretion and calcium mobilization of dispersed guinea pig chief cells. Journal of Cellular Physiology. 142(1). 46–54. 3 indexed citations
4.
Sutliff, V. E., Jay A. Cherner, Robert T. Jensen, & Jerry D. Gardner. (1990). Binding of 125I-CCK-8 and 125I-gastrin-I to dispersed chief cells from guinea-pig stomach. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1052(1). 9–16. 12 indexed citations
5.
Cherner, Jay A., et al.. (1989). Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group.. PubMed. 84(7). 769–74. 8 indexed citations
6.
Cherner, Jay A., et al.. (1989). Ability of prostaglandin to reduce ethanol injury to dispersed chief cells from guinea pig stomach. American Journal of Physiology-Gastrointestinal and Liver Physiology. 256(4). G704–G714. 19 indexed citations
7.
Beauchamp, R. Daniel, J. A. Barnard, Carol M. McCutchen, Jay A. Cherner, & Robert J. Coffey. (1989). Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal.. Journal of Clinical Investigation. 84(3). 1017–1023. 209 indexed citations
8.
Cherner, Jay A., et al.. (1989). Cholecystokinin-induced desensitization of pepsinogen secretion from chief cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 256(5). G837–G845. 5 indexed citations
9.
Cherner, Jay A., et al.. (1988). Gastrointestinal Dysfunction in Systemic Mastocytosis. Gastroenterology. 95(3). 657–667. 105 indexed citations
10.
Cherner, Jay A., et al.. (1988). Functionally distinct receptors for cholecystokinin and gastrin on dispersed chief cells from guinea pig stomach. American Journal of Physiology-Gastrointestinal and Liver Physiology. 254(2). G151–G155. 25 indexed citations
11.
McArthur, K.E., Martin J. Collen, Jay A. Cherner, et al.. (1986). Omeprazole: An Effective Drug for Zollinger-Ellison Syndrome. Scandinavian Journal of Gastroenterology. 21(sup118). 182–183. 4 indexed citations
12.
Cherner, Jay A., et al.. (1986). Selective Venous Sampling for Gastrin to Localize Gastrinomas. Annals of Internal Medicine. 105(6). 841–847. 88 indexed citations
13.
Maton, Paul N., Thomas M. O’Dorisio, K.E. McArthur, et al.. (1985). Effect of a Long-Acting Somatostatin Analogue (SMS 201–995) in a Patient with Pancreatic Cholera. New England Journal of Medicine. 312(1). 17–21. 153 indexed citations
14.
McArthur, K.E., Martin J. Collen, Jay A. Cherner, et al.. (1985). Omeprazole: Effective, Convenient Therapy for Zollinger—Ellison Syndrome. Gastroenterology. 88(4). 939–944. 110 indexed citations
15.
Collen, Martin J., K.E. McArthur, Jay A. Cherner, et al.. (1985). Comparison of Famotidine with Ranitidine and Cimetidine in the Treatment of Zollinger-Ellison Syndrome. Digestion. 32(1). 59–61. 2 indexed citations
16.
Howard, John M., A.N. Chremos, Martin J. Collen, et al.. (1985). Famotidine, a New, Potent, Long-Acting Histamine H2-Receptor Antagonist: Comparison With Cimetidine and Ranitidine in the Treatment of Zollinger-Ellison Syndrome. Gastroenterology. 88(4). 1026–1033. 154 indexed citations
17.
Jensen, Robert T., Martin J. Collen, K.E. McArthur, et al.. (1984). Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.. PubMed. 77(5B). 90–105. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026